Across TCGA pan-cancer cohorts, DNAJB1P1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated DNAJB1P1 data layer.
The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher DNAJB1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJB1P1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SARC show a favorable association.
OV, BRCA, and KIRP are the cancer types where DNAJB1P1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.